| Financial Year |
March 31 2023 |
| Monetary Funds |
114,139,716.02 |
| Held-for-trading Financial Assets |
65,683,992.03 |
| Notes Receivable |
2,216,527.60 |
| Accounts Receivable |
235,679,121.50 |
| Advances to Suppliers |
16,845,395.51 |
| Other Receivables |
6,832,471.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,500,000.00 |
| Inventories |
66,988,985.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
60,374,450.10 |
| Other Current Assets |
35,800,318.54 |
| Total Current Assets |
754,155,949.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
488,590,941.04 |
| Long-term Equity Investment |
65,122,134.57 |
| Investment Properties |
-- |
| Fixed Assetes |
50,692,544.82 |
| Under-construction Projects |
63,768,477.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
295,651,231.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,951,176.46 |
| Deferred Income Tax Assets |
19,267,071.76 |
| Other Non-Current Assets |
5,458,805.71 |
| Sub-Total of Non-Current Assets |
1,006,377,670.53 |
| Total Assets |
1,760,533,619.67 |
| Short-Term Loans |
78,378,403.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
31,000,868.41 |
| Accounts Payable |
275,835,695.13 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,837,549.90 |
| Taxes Payable |
2,755,653.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,709,879.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
39,794,324.07 |
| Other Current Liabilities |
974,797.47 |
| Sub-Total of Current Liabilities |
455,219,040.98 |
| Long-term Loans |
410,858,553.27 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
25,069,910.53 |
| Deferred Income Tax Liabilities |
6,713,384.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
451,600,262.34 |
| Total Liabilities |
906,819,303.32 |
| Paid-In Capital(Or Share Stock) |
132,132,956.00 |
| Capital Surplus |
346,251,802.49 |
| Surplus Reserve |
39,663,702.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
327,996,253.12 |
| Minority Stockholder's Interest |
7,184,731.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
846,529,585.23 |
| Owner's Equity（Stockholder's Equity） |
853,714,316.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,760,533,619.67 |
